| Clinical data | |
|---|---|
| Other names | HR-459 |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C19H19N3 |
| Molar mass | 289.382 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Perafensine (INN; development codeHR-459) is adrug which was investigated as anantidepressant but was never marketed.[1] It has been reported to antagonize the effects ofreserpine and toinhibit thereuptake ofnorepinephrine (norepinephrine reuptake inhibitor); whether it also affects the reuptake ofserotonin ordopamine is unclear.[2]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |